8
Jul 2026
Investigational drug ameliorates neuronal DNA damage and inflammation in Alzheimer's model
Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease.
Stay Informed!
8
Jul 2026
Review highlights pregnancy and miscarriage rates among transmasculine people
A recent review of published research provides some evidence that a small but noteworthy minority of transmasculine people (trans, nonbinary, and other gender expansive people who were assigned female at birth) have pregnancies (6%–9%) and children (4%–9%), including after transition.
8
Jul 2026
New study identifies shared risk factors for breast cancer and atrial fibrillation
Alcohol use and smoking were linked to breast cancer and atrial fibrillation/flutter in women ages 55 years and older in multiple regions of the world, according to new, independent research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
8
Jul 2026
Asthma care is evolving. How FeNO testing is changing the way we treat asthma
Bedfont® Scientific Limited, an innovative leader in breath analysis and Fractional exhaled Nitric Oxide (FeNO) testing for asthma care with the NObreath®, welcomes the news that over 1 million people with asthma are now using combination inhalers following the joint 2024 asthma guidelines from the National Institute for Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN).
8
Jul 2026
Asthma care is evolving. How FeNO testing is changing the way we treat asthma
Bedfont® Scientific Limited, an innovative leader in breath analysis and Fractional exhaled Nitric Oxide (FeNO) testing for asthma care with the NObreath®, welcomes the news that over 1 million people with asthma are now using combination inhalers following the joint 2024 asthma guidelines from the National Institute for Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN).
8
Jul 2026
Asthma care is evolving. How FeNO testing is changing the way we treat asthma
Bedfont® Scientific Limited, an innovative leader in breath analysis and Fractional exhaled Nitric Oxide (FeNO) testing for asthma care with the NObreath®, welcomes the news that over 1 million people with asthma are now using combination inhalers following the joint 2024 asthma guidelines from the National Institute for Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN).
8
Jul 2026
New gene therapy strategy uses the brain's own glymphatic transport system for drug delivery
A new study describes a gene therapy strategy that uses the brain's own glymphatic transport system to distribute engineered viral vectors throughout the brain.
8
Jul 2026
Study explains long-term ocular symptoms following mild COVID-19
Mild COVID-19 can cause severe and long-lasting eye problems, according to a study from Linköping University, Sweden.
8
Jul 2026
Bio-Techne launches expanded R&D Systems AI-Engineered Designer Protein Portfolio
Bio-Techne Corporation, a global provider of life science tools, reagents, and diagnostic products, today announced the launch of new additions to its R&D Systems™ AI-Engineered Designer Protein portfolio, designed to improve reproducibility and performance across advanced cell culture and cell therapy development workflows.
8
Jul 2026
Sexual and gender minority populations are less likely to receive cancer screening
A study reveals significant disparities in cancer screening rates among sexual and gender minorities, highlighting the need for equitable healthcare access.
